Filing Details
- Accession Number:
- 0001209191-10-029112
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-05-19 13:00:00
- Reporting Period:
- 2010-05-17
- Filing Date:
- 2010-05-19
- Accepted Time:
- 2010-05-19 19:17:03
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1333170 | Nxstage Medical Inc. | NXTM | Electromedical & Electrotherapeutic Apparatus (3845) | 043454702 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1341407 | S David Utterberg | C/O Nxstage Medical, Inc. 439 South Union Street, 5Th Floor Lawrence MA 01843 | Yes | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2010-05-17 | 404,000 | $13.64 | 8,031,309 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-05-18 | 173,424 | $13.21 | 7,857,885 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-05-19 | 248,609 | $12.32 | 7,609,276 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2010.
- The shares were sold in multiple transactions on May 17, 2010 at an actual sale price ranging from $13.39 to $14.12 per share. The price reported reflects the weighted average sale price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full informaiton regarding the number of shares sold at each separate price.
- The shares were sold in multiple transactions on May 18, 2010 at an actual sale price ranging from $13.00 to $13.70 per share. The price reported reflects the weighted average sale price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full informaiton regarding the number of shares sold at each separate price.
- The shares were sold in multiple transactions on May 19, 2010 at an actual sale price ranging from $12.14 to $12.84 per share. The price reported reflects the weighted average sale price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full informaiton regarding the number of shares sold at each separate price.
Billionaire Hedge Funds
